Press Release

Wednesday, 02.10.2024

Apersys Successfully Completes Stage 1 ISO 13485 Audit

Apersys company logo with tagline
Tuesday, 03.09.2024

Liver4Life is now Apersys AG

Tuesday, 02.04.2024

Apersys device enables pharmacological-induced defatting of human liver

Thursday, 20.03.2024

Apersys granted Breakthrough Device Designation from the FDA

Tuesday, 31.05.2023

Cutting-edge machine enables fat removal from human liver 

Tuesday, 31.05.2022

First in-human liver transplant after 3 days perfusion

For media enquiries
Members of the media can contact us at hello@apersys.com

Apersys AG

Apersys AG

c/o ETH Zürich

Weinbergstrasse 35

WEH Floor F, 8092 Zürich

Switzerland

Privacy Notice

Imprint

© Apersys 2024
All rights reserved

Get in Touch

Linkedin X-twitter Envelope